UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by First Affirmative Financial Network

First Affirmative Financial Network lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,641 shares of the healthcare conglomerate’s stock after purchasing an additional 37 shares during the quarter. First Affirmative Financial Network’s holdings in UnitedHealth Group were worth $960,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Harbor Investment Advisory LLC grew its position in UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after buying an additional 1,129 shares during the last quarter. Austin Private Wealth LLC raised its position in shares of UnitedHealth Group by 9.8% during the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after purchasing an additional 111 shares during the period. Capital Insight Partners LLC boosted its position in shares of UnitedHealth Group by 3.8% in the 1st quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after purchasing an additional 332 shares during the period. Collective Family Office LLC lifted its stake in UnitedHealth Group by 4.3% during the first quarter. Collective Family Office LLC now owns 1,577 shares of the healthcare conglomerate’s stock valued at $780,000 after buying an additional 65 shares in the last quarter. Finally, Global Assets Advisory LLC purchased a new position in shares of UnitedHealth Group in the first quarter worth approximately $282,469,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. Truist Financial raised their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Robert W. Baird upped their price target on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. UBS Group lifted their target price on UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a research note on Thursday, July 18th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and raised their price target for the stock from $481.00 to $647.00 in a report on Wednesday, July 17th. Finally, KeyCorp started coverage on shares of UnitedHealth Group in a research report on Friday. They issued an “overweight” rating and a $675.00 target price for the company. Two investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average price target of $617.37.

Check Out Our Latest Stock Report on UNH

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 0.0 %

NYSE:UNH opened at $597.87 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94. The company’s 50 day moving average is $583.64 and its 200-day moving average is $530.81. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market cap of $550.27 billion, a price-to-earnings ratio of 36.54, a P/E/G ratio of 1.65 and a beta of 0.58.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the previous year, the company posted $6.14 earnings per share. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.